Nitto Avecia
Marc Gomez Caminals, PhD has a diverse and extensive work experience. Marc currently serves as the Director of Business Development at Nitto Denko Avecia Inc. since March 2018. Prior to this, they worked as the Business Development Manager at Uriach from July 2015 to March 2018, and at EFARMES (LACER Group) from June 2014 to June 2015. Marc also gained experience as a Sales Area Manager at BCN Peptides from May 2011 to June 2014, and as an R&D assistant from January 2006 to May 2011. Additionally, they completed an internship at the Center for Genomic Regulation (CRG) from September 2004 to October 2005, and worked as a research collaboration fellow at the Department of Cell Biology of Universitat de Barcelona from February 2004 to July 2004.
Marc Gomez Caminals, PhD obtained their Bachelor's degree in Biochemistry from Universitat de Barcelona, from 2002 to 2004. Marc then went on to pursue a PhD in Organic Chemistry from the same university, completing it from 2006 to 2011. Additionally, Marc's education history includes attending Escola Proa, although the specific years and degree obtained from this institution are not provided.
This person is not in any teams
This person is not in any offices
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.